Literature DB >> 35145297

Immunogenic cell stress and death.

Guido Kroemer1,2,3, Lorenzo Galluzzi4,5,6, Claudia Galassi7, Laurence Zitvogel8,9,10,11,12.   

Abstract

Dying mammalian cells emit numerous signals that interact with the host to dictate the immunological correlates of cellular stress and death. In the absence of reactive antigenic determinants (which is generally the case for healthy cells), such signals may drive inflammation but cannot engage adaptive immunity. Conversely, when cells exhibit sufficient antigenicity, as in the case of infected or malignant cells, their death can culminate with adaptive immune responses that are executed by cytotoxic T lymphocytes and elicit immunological memory. Suggesting a key role for immunogenic cell death (ICD) in immunosurveillance, both pathogens and cancer cells evolved strategies to prevent the recognition of cell death as immunogenic. Intriguingly, normal cells succumbing to conditions that promote the formation of post-translational neoantigens (for example, oxidative stress) can also drive at least some degree of antigen-specific immunity, pointing to a novel implication of ICD in the etiology of non-infectious, non-malignant disorders linked to autoreactivity.
© 2022. Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35145297     DOI: 10.1038/s41590-022-01132-2

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  231 in total

Review 1.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

Review 2.  Linking cellular stress responses to systemic homeostasis.

Authors:  Lorenzo Galluzzi; Takahiro Yamazaki; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2018-11       Impact factor: 94.444

Review 3.  Origin and Consequences of Necroinflammation.

Authors:  Maysa Sarhan; Walter G Land; Wulf Tonnus; Christian P Hugo; Andreas Linkermann
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 4.  Necroptosis in development, inflammation and disease.

Authors:  Ricardo Weinlich; Andrew Oberst; Helen M Beere; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-21       Impact factor: 94.444

Review 5.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

Review 6.  Emerging connectivity of programmed cell death pathways and its physiological implications.

Authors:  Sammy Bedoui; Marco J Herold; Andreas Strasser
Journal:  Nat Rev Mol Cell Biol       Date:  2020-09-01       Impact factor: 94.444

Review 7.  Live to die another way: modes of programmed cell death and the signals emanating from dying cells.

Authors:  Yaron Fuchs; Hermann Steller
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05-20       Impact factor: 94.444

Review 8.  Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Authors:  Lorenzo Galluzzi; Ilio Vitale; Stuart A Aaronson; John M Abrams; Dieter Adam; Patrizia Agostinis; Emad S Alnemri; Lucia Altucci; Ivano Amelio; David W Andrews; Margherita Annicchiarico-Petruzzelli; Alexey V Antonov; Eli Arama; Eric H Baehrecke; Nickolai A Barlev; Nicolas G Bazan; Francesca Bernassola; Mathieu J M Bertrand; Katiuscia Bianchi; Mikhail V Blagosklonny; Klas Blomgren; Christoph Borner; Patricia Boya; Catherine Brenner; Michelangelo Campanella; Eleonora Candi; Didac Carmona-Gutierrez; Francesco Cecconi; Francis K-M Chan; Navdeep S Chandel; Emily H Cheng; Jerry E Chipuk; John A Cidlowski; Aaron Ciechanover; Gerald M Cohen; Marcus Conrad; Juan R Cubillos-Ruiz; Peter E Czabotar; Vincenzo D'Angiolella; Ted M Dawson; Valina L Dawson; Vincenzo De Laurenzi; Ruggero De Maria; Klaus-Michael Debatin; Ralph J DeBerardinis; Mohanish Deshmukh; Nicola Di Daniele; Francesco Di Virgilio; Vishva M Dixit; Scott J Dixon; Colin S Duckett; Brian D Dynlacht; Wafik S El-Deiry; John W Elrod; Gian Maria Fimia; Simone Fulda; Ana J García-Sáez; Abhishek D Garg; Carmen Garrido; Evripidis Gavathiotis; Pierre Golstein; Eyal Gottlieb; Douglas R Green; Lloyd A Greene; Hinrich Gronemeyer; Atan Gross; Gyorgy Hajnoczky; J Marie Hardwick; Isaac S Harris; Michael O Hengartner; Claudio Hetz; Hidenori Ichijo; Marja Jäättelä; Bertrand Joseph; Philipp J Jost; Philippe P Juin; William J Kaiser; Michael Karin; Thomas Kaufmann; Oliver Kepp; Adi Kimchi; Richard N Kitsis; Daniel J Klionsky; Richard A Knight; Sharad Kumar; Sam W Lee; John J Lemasters; Beth Levine; Andreas Linkermann; Stuart A Lipton; Richard A Lockshin; Carlos López-Otín; Scott W Lowe; Tom Luedde; Enrico Lugli; Marion MacFarlane; Frank Madeo; Michal Malewicz; Walter Malorni; Gwenola Manic; Jean-Christophe Marine; Seamus J Martin; Jean-Claude Martinou; Jan Paul Medema; Patrick Mehlen; Pascal Meier; Sonia Melino; Edward A Miao; Jeffery D Molkentin; Ute M Moll; Cristina Muñoz-Pinedo; Shigekazu Nagata; Gabriel Nuñez; Andrew Oberst; Moshe Oren; Michael Overholtzer; Michele Pagano; Theocharis Panaretakis; Manolis Pasparakis; Josef M Penninger; David M Pereira; Shazib Pervaiz; Marcus E Peter; Mauro Piacentini; Paolo Pinton; Jochen H M Prehn; Hamsa Puthalakath; Gabriel A Rabinovich; Markus Rehm; Rosario Rizzuto; Cecilia M P Rodrigues; David C Rubinsztein; Thomas Rudel; Kevin M Ryan; Emre Sayan; Luca Scorrano; Feng Shao; Yufang Shi; John Silke; Hans-Uwe Simon; Antonella Sistigu; Brent R Stockwell; Andreas Strasser; Gyorgy Szabadkai; Stephen W G Tait; Daolin Tang; Nektarios Tavernarakis; Andrew Thorburn; Yoshihide Tsujimoto; Boris Turk; Tom Vanden Berghe; Peter Vandenabeele; Matthew G Vander Heiden; Andreas Villunger; Herbert W Virgin; Karen H Vousden; Domagoj Vucic; Erwin F Wagner; Henning Walczak; David Wallach; Ying Wang; James A Wells; Will Wood; Junying Yuan; Zahra Zakeri; Boris Zhivotovsky; Laurence Zitvogel; Gerry Melino; Guido Kroemer
Journal:  Cell Death Differ       Date:  2018-01-23       Impact factor: 12.067

9.  Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

Authors:  Noelia Casares; Marie O Pequignot; Antoine Tesniere; François Ghiringhelli; Stéphan Roux; Nathalie Chaput; Elise Schmitt; Ahmed Hamai; Sandra Hervas-Stubbs; Michel Obeid; Frédéric Coutant; Didier Métivier; Evelyne Pichard; Pierre Aucouturier; Gérard Pierron; Carmen Garrido; Laurence Zitvogel; Guido Kroemer
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

Review 10.  Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.

Authors:  Lorenzo Galluzzi; Ilio Vitale; Sarah Warren; Sandy Adjemian; Patrizia Agostinis; Aitziber Buqué Martinez; Timothy A Chan; George Coukos; Sandra Demaria; Eric Deutsch; Dobrin Draganov; Richard L Edelson; Silvia C Formenti; Jitka Fucikova; Lucia Gabriele; Udo S Gaipl; Sofia R Gameiro; Abhishek D Garg; Encouse Golden; Jian Han; Kevin J Harrington; Akseli Hemminki; James W Hodge; Dewan Md Sakib Hossain; Tim Illidge; Michael Karin; Howard L Kaufman; Oliver Kepp; Guido Kroemer; Juan Jose Lasarte; Sherene Loi; Michael T Lotze; Gwenola Manic; Taha Merghoub; Alan A Melcher; Karen L Mossman; Felipe Prosper; Øystein Rekdal; Maria Rescigno; Chiara Riganti; Antonella Sistigu; Mark J Smyth; Radek Spisek; John Stagg; Bryan E Strauss; Daolin Tang; Kazuki Tatsuno; Stefaan W van Gool; Peter Vandenabeele; Takahiro Yamazaki; Dmitriy Zamarin; Laurence Zitvogel; Alessandra Cesano; Francesco M Marincola
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751

View more
  38 in total

1.  A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapy.

Authors:  Oliver Kepp; Guido Kroemer
Journal:  Oncoimmunology       Date:  2022-07-08       Impact factor: 7.723

Review 2.  Nanodrugs Manipulating Endoplasmic Reticulum Stress for Highly Effective Antitumor Therapy.

Authors:  Yuting Xiang; Min Liu; Yunrong Yang; Yubo Wang; Yige Qiu; Shiqi Tu; Yitian Jiang; Yayun Nan; Xiaojie Zhang; Qiong Huang
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

3.  Is ferroptosis immunogenic? The devil is in the details!

Authors:  Oliver Kepp; Guido Kroemer
Journal:  Oncoimmunology       Date:  2022-09-23       Impact factor: 7.723

4.  Nanoparticles releasing immunogenic cell death inducers upon near-infrared light exposure.

Authors:  Oliver Kepp; Giulia Cerrato; Allan Sauvat; Guido Kroemer
Journal:  Oncoimmunology       Date:  2022-10-04       Impact factor: 7.723

5.  PDIA3 as a potential bridge between immunogenic cell death and autoreactivity.

Authors:  Jonathan G Pol; Céleste Plantureux; María Pérez-Lanzón; Guido Kroemer
Journal:  Oncoimmunology       Date:  2022-09-30       Impact factor: 7.723

6.  Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses.

Authors:  Jessica K Mandula; Shiun Chang; Eslam Mohamed; Rachel Jimenez; Rosa A Sierra-Mondragon; Darwin C Chang; Alyssa N Obermayer; Carlos M Moran-Segura; Satyajit Das; Julio A Vazquez-Martinez; Karol Prieto; Ann Chen; Keiran S M Smalley; Brian Czerniecki; Peter Forsyth; Richard C Koya; Brian Ruffell; Juan R Cubillos-Ruiz; David H Munn; Timothy I Shaw; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Cancer Cell       Date:  2022-09-22       Impact factor: 38.585

7.  Immunogenic stress induced by local anesthetics injected into neoplastic lesions.

Authors:  Lucillia Bezu; Oliver Kepp; Guido Kroemer
Journal:  Oncoimmunology       Date:  2022-05-16       Impact factor: 7.723

Review 8.  Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.

Authors:  Weitong Gao; Xueying Wang; Yang Zhou; Xueqian Wang; Yan Yu
Journal:  Signal Transduct Target Ther       Date:  2022-06-20

9.  Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.

Authors:  Raquel S Laureano; Jenny Sprooten; Isaure Vanmeerbeerk; Daniel M Borras; Jannes Govaerts; Stefan Naulaerts; Zwi N Berneman; Benoit Beuselinck; Kalijn F Bol; Jannie Borst; An Coosemans; Angeliki Datsi; Jitka Fučíková; Lisa Kinget; Bart Neyns; Gerty Schreibelt; Evelien Smits; Rüdiger V Sorg; Radek Spisek; Kris Thielemans; Sandra Tuyaerts; Steven De Vleeschouwer; I Jolanda M de Vries; Yanling Xiao; Abhishek D Garg
Journal:  Oncoimmunology       Date:  2022-07-04       Impact factor: 7.723

10.  Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer.

Authors:  Pan Juncheng; Adrien Joseph; Antoine Lafarge; Isabelle Martins; Florine Obrist; Jonathan Pol; Ester Saavedra; Sijing Li; Allan Sauvat; Giulia Cerrato; Sarah Lévesque; Marion Leduc; Oliver Kepp; Sylvère Durand; Fanny Aprahamian; Nitharsshini Nirmalathansan; Judith Michels; Guido Kroemer; Maria Castedo
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.